Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Adjunctive Oral Magnesium Supplementation Prolong the Effect of Botulinum Toxin Type A in Patients With Excessive Gingival Display? A Randomized Controlled Clinical Trial

NCT07874009 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT07874009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07874009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Adjunctive Oral Magnesium Supplementation Prolong the Effect of Botulinum Toxin Type A in Patients With Excessive Gingival Display? A Randomized Controlled Clinical Trial
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
October 1, 2026
Completion date
October 30, 2027
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

botulinum toxin type a, excessive gingival display, magnesium, oral